Research News

Keep up to date with new and exciting research projects being undertaken at East Metropolitan Health Service (EMHS).

Congratulations RPH Head of Cardiology - $1.8M funding to investigate treatment of a common heart condition

Royal Perth Hospital (RPH) Cardiologist, Professor Graham Hillis, has been awarded more than $1.8M in funding for his research team to investigate treatment of a common heart condition.

The funding is from the Federal Government’s Medical Research Future Fund which aims to support researchers to make the next big medical discoveries that benefit all Australians. It will support an international team that will investigate if early valve replacement improves the outcome for patients with severe aortic stenosis, or narrowing of the valve between the heart and the major artery that carries blood around the body.

Read more here.

New Leukemia treatment dubbed 'a magic bullet'

Researchers from RPH’s Haematology department have helped uncover a new drug that can contain/treat a type of aggressive Leukemia. The immunotherapy is so effective they've dubbed it "the magic bullet".

The magic bullet includes two pills taken every day and a small injection of chemotherapy seven days a month. It's a form of immunotherapy that works by targeting mutant proteins in the blood.

Read the news article to learn more.

Photograph of Christopher LeviBuilding a Career in Clinical Research presentation

On 6 June 2019 we were delighted to host Professor Christopher Levi, Executive Director, Maridulu Budyari Gumal: Sydney Partnership for Health, Education, Research and Enterprise (SPHERE).

Professor Levi gave a presentation to inspire our early-career researchers. He recounted lessons from his career as a clinical researcher, including the need to persevere in the face of set-backs, the importance of building enduring relationships with mentors, and the benefits of ‘co-designing’ research with clinicians and patients. It was a terrific opportunity to hear from and meet with a world-renowned leader in translating research into clinical practice.

We thank Professor Levi for taking time while in Perth to present at Science on the Swan 2019.

Putting a new thinking cap on – 3D printing skulls

Congratulations to the tissue engineering team from our Health Technology Management Unit, Cell and Tissue Therapy WA and the Department of Neurosurgery who have now progressed to the final round of the 2018 WA Innovator of the Year Awards.

The team of Dr Alan Kop (pictured, left) Dr David Morrison (pictured, right), Dr Stephen Honeybul and Dr Marian Sturm are now competing with only four other finalists in the Emerging Innovation Category of these important awards.

The team’s exciting research program involves a clinical trial that is underway to explore how tissue engineering can be applied to harvest the power of stem cells and utilise advanced manufacturing techniques such as 3D printing.

Learn more about this exciting research.

Managing medication for people living with dementia

People with dementia often have coexisting health conditions that require medication.

The Medication Appropriateness Tool for Comorbid Health Conditions in Dementia (MATCH-D) study aims to determine to what extent improved medication management produces better health and functional outcomes for people with dementia.

Led by Royal Perth Hospital's Associate Professor Chris Etherton-Beer, the study is supported by a $586,000 grant from the National Health and Medical Research Council.

Learn more about the MATCH-D study.

Treating low blood pressure in sepsis patients

Sepsis is a life-threatening illness caused by the body’s response to an infection. When low blood pressure occurs in a sepsis patient the risk of organ failure is increased.

A team led by Royal Perth Hospital Emergency Medicine Consultant Dr Stephen MacDonald is trialling a treatment called Restricted Fluid Resuscitation in Sepsis-associated Hypotension (REFRESH).

The trial uses rapid intravenous fluids to treat hypotension rather than the more traditional vasopressor medications.

The results will be used to inform a large-scale international clinical trial.

Last Updated: 20/11/2019